OTC ANTACID LABEL WARNING AGAINST USE IN "EXCESSIVELY" FULL STOMACH
This article was originally published in The Tan Sheet
Executive Summary
OTC ANTACID LABEL WARNING AGAINST USE IN "EXCESSIVELY" FULL STOMACH was recommended by Church & Dwight in May 2 comments to FDA. Responding to the agency's Feb. 2 proposal calling for label warnings on sodium bicarbonate antacids, Church & Dwight suggested that FDA "consider requiring that all OTC antacids bear a clear warning against use when the consumer has the feeling/sensation that the stomach is excessively full -- including a statement that use in these circumstances may lead to serious stomach injury."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning